Ether (ETH), a leading cryptocurrency, traded at $2,363.96, marking a 1.43% decline over the past 24 hours as of 10:14 a.m. ET on Saturday. This price movement reflects ongoing volatility in digital asset markets, which investors should monitor closely. The decline may influence trading strategies and market sentiment in the near term.
Ether's recent price movement is noted here as context. For readers following cryptocurrency markets, Pluang data shows that out of 50 major cryptocurrencies, 5 rose and 43 fell today. Notable movers include ADA at Rp3.743 with a -4.76% change, SUSHI at Rp3.722 with a -4.65% change, and AXS at Rp17.405 with a -4.58% change. This snapshot is as of Oct 24, 2026 21:01 WIB.
The Royal Canadian Legion has launched its 2026 National Poppy Campaign introducing a new contactless donation method using smartphones, supported by BMO and Toucan Giving technology. This innovation allows volunteers to collect donations via debit, ...
XBiotech Inc. announced the election of Jan-Paul Simard as Co-Chief Executive Officer alongside current CEO Dr. Sushma Shivaswamy, effective October 23, 2026. This leadership change aims to leverage their complementary skills and scientific expertise...
XBiotech Inc. announced the appointment of Sushma Shivaswamy and Jan-Paul Simard as co-chief executive officers, effective October 23, 2026. Shivaswamy, with 17 years at the company, has led scientific operations and was interim CEO since December 20...
Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...
Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...
